List view / Grid view

Ian Anderson (Lonza)



The benefits of mass spectrometry for expediting biologics to patients

20 September 2023 | By , ,

A key element of development for new molecular format biological products is to leverage the appropriate analytical tools to enhance product and process understanding throughout the development lifecycle. Here, Ian Anderson, Mostafa Zarei and Qifeng Zhang at Lonza highlight the benefits of using mass spectrometry technologies to accelerate and de-risk product…